Winter, Yaroslav
Sandner, Katharina
Vieth, Thomas Ludger
Melzer, Nico
Klimpe, Sven
Meuth, Sven G.
Groppa, Sergiu
Funding for this research was provided by:
Universitätsmedizin der Johannes Gutenberg-Universität Mainz
Article History
Accepted: 5 September 2022
First Online: 30 September 2022
Declarations
:
: Open Access funding enabled and organized by Projekt DEAL. No finding was provided for this study.
: YW reports honoraria for educational presentations and consultations from Arvelle Therapeutics, Bayer AG, BIAL, Eisai, LivaNova, Novartis, and UCB Pharma. SG received compensation for professional services from Abbott, AbbVie, Bial, Medtronic, UCB, and Zambon; research grants from Abbott, Boston Scientific, MagVenture, German Research Council, Innovations Fund and German Ministry of Education and Health. NM has received honoraria for lecturing and travel expenses for attending meetings from Biogen Idec, GlaxoSmith Kline, Teva, Novartis Pharma, Bayer Healthcare, Genzyme, Alexion Pharamceuticals, Fresenius Medical Care, Diamed, UCB Pharma, and BIAL, has received royalties for consulting from UCB Pharma, and Alexion Pharmaceuticals, and has received financial research support from Euroimmun, Fresenius Medical Care, Diamed, Alexion Pharmaceuticals, and Novartis Pharma. SK has received honoraria for presentations and teaching courses from UCB Pharma and Novartis Pharma, and has been invited to congresses and educational meetings by UCB Pharma and Eisai Pharma. SGM received honoraria for lecturing and travel expenses for attending meetings from Almirall, Amicus Therapeutics Germany, Bayer Health Care, Biogen, Celgene, Diamed, Genzyme, MedDay Pharmaceuticals, Merck Serono, Novartis, Novo Nordisk, ONO Pharma, Roche, Sanofi-Aventis, Chugai Pharma, QuintilesIMS, and Teva. His research is funded by the German Ministry for Education and Research (BMBF), Deutsche Forschungsgemeinschaft (DFG), Else Kröner Fresenius Foundation, German Academic Exchange Service, Hertie Foundation, Interdisciplinary Center for Clinical Studies (IZKF) Muenster, German Foundation Neurology, and by Almirall, Amicus Therapeutics Germany, Biogen, Diamed, Fresenius Medical Care, Genzyme, Merck Serono, Novartis, ONO Pharma, Roche, and Teva. KS and TV declare no conflicts of interest.
: This study was approved by the ethics committee of the Rhineland-Palatinate Chamber of Physicians.
: All patients signed informed consent for participation in this study.
: Not applicable.
: Data can be received on request from the corresponding author.
: Not applicable.
: Conceptualization and design: YW, SG. Methodology and data collection: YW, KS, SG. Analysis and interpretation: YW, KS, TV, SG. Writing, original draft preparation: YW, KS, TV, NM, SK, SGM, SG. Writing, reviewing, and editing: YW, KS, TV, NM, SK, SGM, SG. All authors have read and approved the final submitted manuscript and agree to be accountable for the work.